These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12707519)

  • 1. [In vitro susceptibility of different erythromycin-resistant phenotypes of Streptococcus pyogenes to moxifloxacin and other fluoroquinolones].
    Novielllo S; Ianniello F; Esposito S; Novelli A
    Infez Med; 2000; 1(8):34-38. PubMed ID: 12707519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus.
    Esposito S; Noviello S; Ianniello F; Novelli A
    Chemotherapy; 2000; 46(1):23-7. PubMed ID: 10601794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents.
    Rubio MC; Goñi P; Vergara Y; Seral C; García C; Gómez-Lus P; Gómez-Lus R
    J Chemother; 1999 Jun; 11(3):191-4. PubMed ID: 10435680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.
    Tankovic J; Bachoual R; Ouabdesselam S; Boudjadja A; Soussy CJ
    J Antimicrob Chemother; 1999 May; 43 Suppl B():19-23. PubMed ID: 10382871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
    J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of older and newer fluoroquinolones against respiratory tract pathogens.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2000; 46(5):309-14. PubMed ID: 10965095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 2002 Dec; 50(6):907-13. PubMed ID: 12461012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin.
    Klugman KP; Capper T
    J Antimicrob Chemother; 1997 Dec; 40(6):797-802. PubMed ID: 9462430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.
    Reinert RR; Schlaeger JJ; Lütticken R
    J Antimicrob Chemother; 1998 Dec; 42(6):803-6. PubMed ID: 10052905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
    Esposito S; Noviello S; Ianniello F
    J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
    Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
    Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [National multicenter study of the in vitro activity of moxifloxacin against respiratory tract pathogens. Spanish Study Group on Moxifloxacin].
    Loza E; Morosini M; Negri MC; Almaraz F; Cantón R; Baquero F
    Rev Esp Quimioter; 2000 Mar; 13(1):37-43. PubMed ID: 10855023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.
    Ackermann G; Degner A; Cohen SH; Silva J; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):599-603. PubMed ID: 12615860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
    Descheemaeker P; Chapelle S; Lammens C; Hauchecorne M; Wijdooghe M; Vandamme P; Ieven M; Goossens H
    J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.
    Montanari MP; Mingoia M; Giovanetti E; Varaldo PE
    J Clin Microbiol; 2001 Apr; 39(4):1311-5. PubMed ID: 11283047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
    Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Frémaux A; Sissia G; Geslin P
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():9-14. PubMed ID: 10404331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.